{"id":"NCT03971422","sponsor":"UCB Biopharma SRL","briefTitle":"A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis","officialTitle":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-06-03","primaryCompletion":"2021-08-31","completion":"2021-10-26","firstPosted":"2019-06-03","resultsPosted":"2023-08-21","lastUpdate":"2024-10-21"},"enrollment":200,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Generalized Myasthenia Gravis"],"interventions":[{"type":"DRUG","name":"Rozanolixizumab","otherNames":["UCB7665"]},{"type":"OTHER","name":"Placebo","otherNames":["PBO"]}],"arms":[{"label":"Dosage Regimen 1","type":"EXPERIMENTAL"},{"label":"Dosage Regimen 2","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the MycarinGstudy is to demonstrate the clinical efficacy and to assess safety and tolerability of rozanolixizumab in patients with generalized myasthenia gravis (MG).","primaryOutcome":{"measure":"Change From Baseline to Day 43 in Myasthenia Gravis-Activities of Daily Living (MG-ADL) Score","timeFrame":"Baseline and Day 43","effectByArm":[{"arm":"Placebo","deltaMin":-0.784,"sd":0.488},{"arm":"Rozanolixizumab ~7 mg/kg","deltaMin":-3.37,"sd":0.486},{"arm":"Rozanolixizumab ~10 mg/kg","deltaMin":-3.403,"sd":0.494}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":112,"countries":["United States","Belgium","Canada","Czechia","Denmark","France","Georgia","Germany","Hungary","Italy","Japan","Poland","Russia","Serbia","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":["37059507","39297052","38978809","38099334","33219142"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":67},"commonTop":["Headache","Diarrhoea","Pyrexia","Nausea","Arthralgia"]}}